Modulation of a response signal to distinguish between analyte and background signals

US11464429B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11464429-B2
Application numberUS-201916706098-A
CountryUS
Kind codeB2
Filing dateDec 6, 2019
Priority dateOct 23, 2013
Publication dateOct 11, 2022
Grant dateOct 11, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for modulating a response signal includes introducing functionalized particles into a lumen of subsurface vasculature, wherein the functionalized particles are configured to interact with one or more target analytes present in blood circulating in the subsurface vasculature; and non-invasively detecting the one or more target analytes. A response signal, which may include a background signal and an analyte response signal related to interaction of the functionalized particles with the one or more target analytes, is transmitted from the subsurface vasculature. A modulation configured to alter the response signal such that the analyte response signal is affected differently than the background signal may be applied to a portion of subsurface vasculature. Analyte detection may be achieved by differentiating the analyte response signal from the background signal.

First claim

Opening claim text (preview).

What is claimed is: 1. A method, comprising: detecting an analyte response signal transmitted from within a lumen of subsurface vasculature inside a body, wherein the analyte response signal is indicative of interaction of functionalized particles with one or more target analytes present in blood circulating in the subsurface vasculature; detecting an unbound particle signal transmitted from within the lumen of subsurface vasculature, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes; detecting a background signal; applying a modulation to a portion of the subsurface vasculature, wherein the modulation alters the analyte response signal and the unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and the background signal; and differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation. 2. The method of claim 1 , further comprising introducing the functionalized particles into the lumen of subsurface vasculature by injection, ingestion, inhalation, or transdermally. 3. The method of claim 1 , further comprising: directing an interrogating signal into the subsurface vasculature; and detecting the analyte response signal transmitted from the subsurface vasculature in response to the interrogating signal. 4. The method of claim 1 , wherein the modulation alters the analyte response signal by spatially modulating the functionalized particles that are interacting with the one or more target analytes. 5. The method of claim 1 , wherein the modulation alters one or more properties of the functionalized particles that are interacting with the one or more target analytes. 6. The method of claim 5 , wherein the one or more properties of the functionalized particles comprises one or more of: optical properties, magnetic properties, electric properties, thermal properties, acoustic properties, and physical properties. 7. The method of claim 1 , wherein the functionalized particles each comprise at least one of an antibody, a peptide, a nucleic acid, a protein, a low molecular weight ligand, a polysaccharide, a polyunsaturated fatty acid, a plasmid, or an aptamer. 8. A method, comprising: detecting an analyte response signal transmitted from an environment, wherein the analyte response signal is indicative of interaction of functionalized particles with one or more target analytes; detecting an unbound particle signal transmitted from the environment, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes; detecting a background signal; applying a modulation to a portion of the environment, wherein the modulation alters the analyte response signal and unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and background signal; and differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation. 9. The method of claim 8 , further comprising: directing an interrogating signal into the environment; and detecting the analyte response signal transmitted from the environment in response to the interrogating signal. 10. The method of claim 8 , wherein the environment comprises a living body. 11. The method of claim 10 , wherein the functionalized particles interact with one or more target analytes present in the living body. 12. The method of claim 10 , wherein the functionalized particles are introduced into a body fluid comprising blood, tear fluid, urine, lymph, cerebrospinal fluid, or mucus. 13. The method of claim 10 , further comprising: introducing the functionalized particles into the living body by injection, ingestion, inhalation, or transdermally. 14. The method of claim 8 , wherein the functionalized particles each comprise at least one of an antibody, a peptide, a nucleic acid, a protein, a low molecular weight ligand, a polysaccharide, a polyunsaturated fatty acid, a plasmid, or an aptamer. 15. A device, comprising: a detector that detects: an analyte response signal transmitted from an environment, wherein the analyte response signal is indicative of interaction of one or more target analytes with functionalized particles present in the environment; an unbound particle signal transmitted from the environment, wherein the unbound particle signal is indicative of functionalized particles that are not interacting with the one or more target analytes; and a background signal; a modulation source that alters the analyte response signal and the unbound particle signal, such that the analyte response signal is affected differently than the unbound particle signal and background signal; and a processor that non-invasively detects the one or more target analytes by differentiating the analyte response signal from the unbound particle signal and the background signal based, at least in part, on the modulation. 16. The device of claim 15 , wherein the environment comprises a living body. 17. The device of claim 16 , further comprising a wearable device mountable to an external surface of the living body, wherein the detector is mounted on the wearable device. 18. The device of claim 15 , wherein at least a portion of the modulation source is mounted on the wearable device. 19. The device of claim 15 , wherein the modulation source alters the analyte response signal differently than the background signal. 20. The device of claim 15 , further comprising an interrogating signal source that directs an interrogation signal source into the environment, the analyte response signal being transmitted in response to the interrogating signal.

Assignees

Inventors

Classifications

  • Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves (measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24) · CPC title

  • A61B5/145Primary

    Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06) · CPC title

  • using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339) · CPC title

  • for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

  • for noise prevention, reduction or removal · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11464429B2 cover?
A method for modulating a response signal includes introducing functionalized particles into a lumen of subsurface vasculature, wherein the functionalized particles are configured to interact with one or more target analytes present in blood circulating in the subsurface vasculature; and non-invasively detecting the one or more target analytes. A response signal, which may include a background …
Who is the assignee on this patent?
Verily Life Sciences Llc
What technology area does this patent fall under?
Primary CPC classification A61B5/145. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).